Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 21, 2009; 15(3): 356-365
Published online Jan 21, 2009. doi: 10.3748/wjg.15.356
Published online Jan 21, 2009. doi: 10.3748/wjg.15.356
Case | Sex | Age | Hepatitis virus | Differentiated grade | TNM score |
1 | M | 54 | HBV | WD | T1N0M0 |
2 | M | 60 | HCV | WD | T1N0M0 |
3 | F | 61 | HBV | WD | T2N0M0 |
4 | M | 62 | HBV | WD | T2N0M0 |
5 | M | 58 | HBV | WD | T1N0M0 |
6 | F | 56 | HCV | MD | T3N0M0 |
7 | F | 44 | HBV | WD | T2N0M0 |
8 | M | 49 | HCV | WD | T1N0M0 |
9 | M | 58 | HBV | WD | T2N0M0 |
10 | M | 67 | HCV | PD | T3N0M0 |
11 | M | 69 | HBV | WD | T2N0M0 |
12 | F | 63 | HCV | WD | T1N0M0 |
13 | M | 48 | HCV | MD | T2N0M0 |
14 | F | 63 | HBV | WD | T1N0M0 |
15 | M | 49 | HCV | MD | T1N0M0 |
16 | F | 51 | HBV | PD | T3N1M0 |
17 | M | 65 | HCV | MD | T3N1M0 |
18 | F | 58 | HBV | PD | T4N1M1 |
19 | M | 60 | HBV | MD | T2N1M0 |
20 | F | 56 | HCV | PD | T3N1M1 |
21 | M | 42 | HCV | PD | T3N1M0 |
22 | M | 55 | HBV | PD | T4N1M1 |
23 | M | 66 | HBV | MD | T3N1M0 |
24 | F | 70 | HCV | WD | T2N1M0 |
25 | M | 58 | HBV | PD | T4N1M1 |
26 | M | 53 | HCV | PD | T3N1M0 |
27 | M | 61 | HBV | PD | T4N1M0 |
28 | F | 65 | HBV | MD | T3N1M0 |
29 | M | 59 | HCV | MD | T3N1M1 |
30 | M | 50 | HBV | PD | T3N1M0 |
31 | F | 63 | HCV | PD | T4N1M1 |
32 | M | 66 | HCV | PD | T3N1M0 |
Gene name | Symbola | Accessionb | Fold changec | pN1:pN0d |
Cell adhesion proteins | ||||
CD58 antigen, (lymphocyte function-assocoated antigens) | CD58 | NM_001779 | 7.75 | 2.28 |
Integrin αM | ITGAM | NM_000632 | 5.04 | 2.06 |
Integrin β5 | ITGB5 | NM_002213 | 3.98 | 1.87 |
Opioid-binding protein/cell adhesion molecule-like | OPCML | NM_002545 | ||
Cell membrane receptor | ||||
CD86 antigen, (CD28 antigen ligand 2, B7-2 antigen) | CD86 | NM_006889 | 6.76 | 2.33 |
v-jun sarcoma virus 17 oncogene homolog (avian) | JUN | NM_002228 | 7.43 | 2.27 |
Met proto-oncogene (hepatocyte growth factor receptor) | MET | NM_000245 | 10.11 | 3.46 |
EphA2 | EPHA2 | NM_004431 | 8.26 | 2.13 |
Epidermal growth factor receptor [avian erythroblastic leukemia viral (v-erb-b) oncogene homolog] | EGFR | NM_005228 | 8.35 | 2.62 |
Cell death regulator | ||||
BCL2/adenovirus E1B 19kDa interacing protein 3 | BNIP3 | NM_004052 | 3.88 | 2.29 |
Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | SEMA4D | NM_006378 | 5.71 | 3.64 |
Intracellular signaling | ||||
Rho GDP dissociation inhibitor γ | ARHGDIG | NM_001175 | 5.37 | 1.97 |
Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | RAC3 | AK054993 | 4.63 | 2.07 |
Insulin-like growth factor binding protein 3 | IGFBP3 | M35878 | 5.39 | 2.15 |
Coagulation factor II (thrombin) receptor | F2R | NM_001992 | 6.17 | 2.43 |
Growth/differentiation factor | ||||
Vascular endothelial growth factor C | VEGFC | NM_005429 | 5.68 | 2.47 |
Cell cycle regulator | ||||
Cyclin D1 (PRAD1: parathyroid adenomatosis 1) | CCND1 | NM_053056 | 11.56 | 4.31 |
Cyclin-dependent kinase 4 | CDK4 | NM_000075 | 8.73 | 3.59 |
Others | ||||
Tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) | TIMP3 | NM_000362 | 3.95 | 1.89 |
Ubiquitin-conjugating enzyme E2A (RAD6 homolog) | UBE2A | NM_003336 | 4.38 | 1.95 |
v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | YES1 | NM_005433 | 5.66 | 2.37 |
P450(cytochrome) oxidoreductase | POR | AF258341 | 4.74 | 1.99 |
Matrix metalloproteinase 13 | MMP13 | NM_00247 | 5.67 | 2.45 |
Matrix metalloproteinase 2 (gelatinase A, 72kD gelatinase, 72kD type IV collagenase) | MMP2 | NM_004530 | 7.13 | 3.36 |
Gene name | Symbola | Accessionb | Fold changec | pN1:pN0d |
Cell adhesion proteins | ||||
Desmoplakin (DPI, DPII) | DSP | NM_004415 | -14.22 | 0.24 |
Protocadherin gamma subfamily C, 3 | PCDHGC3 | NM_002588 | -7.88 | 0.41 |
Integrin, beta 4 | ITGB4 | NM_000213 | -13.39 | 0.26 |
Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | ITGA3 | NM_002204 | -6.24 | 0.38 |
Catenin (cadherin-associated protein), alpha 1 (102kD) | CTNNA1 | NM_001903 | -8.53 | 0.37 |
Cadherin 1, type 1, E-cadherin (epithelial) | CDH1 | NM_004360 | -15.85 | 0.25 |
Cell cycle regulator | ||||
Cell division cycle 25B | CDC25B | NM_021784 | -6.90 | 0.46 |
Cyclin-dependent kinase 5 | CDK5 | NM_004935 | -5.51 | 0.48 |
Cyclin D2 | CCND2 | NM_001759 | -6.29 | 0.43 |
Microtubule-associated protein, RP/EB family, member 1 | MAPRE1 | NM_012325 | -13.16 | 0.29 |
Protein phosphatase 1D | PPM1D | NM_003620 | -11.77 | 0.39 |
Ataxia telangiectasia and Rad3 related | ATR | NM_001184 | -7.86 | 0.41 |
Protein phosphatase 2, regulatory subunit B (B56), alpha isoform | PPP2R5A | NM_006243 | -3.89 | 0.49 |
Intracellular signaling | ||||
Mitogen-activated protein kinase 14 | MAPK14 | NM_001315 | -5.67 | 0.43 |
Mitogen-activated protein kinase 7 | MAPK7 | NM_002749 | -7.15 | 0.39 |
Mitogen-activated protein kinase 4 | MAPK4 | NM_002747 | -3.83 | 0.32 |
Small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cell chemoattractant) | SCYB13 | NM_006419 | -4.58 | 0.46 |
Signal transducer and activator of transcription 5B | STAT5B | NM_012448 | -8.13 | 0.37 |
Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1 | SERPINB1 | NM_030666 | -4.47 | 0.48 |
Serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 2 | SERPINB2 | NM_002575 | -5.72 | 0.41 |
SH3-domain binding protein 2 | SH3BP2 | AB000462 | -3.29 | 0.52 |
G protein-coupled receptor kinase 6 | GPRK6 | NM_002082 | -14.12 | 0.29 |
GTP-binding protein ragB | RAGB | NM_016656 | -6.77 | 0.46 |
Protein tyrosine phosphatase, receptor type, F | PTPRF | NM_002840 | -7.21 | 0.34 |
Cell membrane receptor | ||||
EphB6 | EPHB6 | NM_004445 | -12.88 | 0.38 |
Kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4) | KAI1 | NM_002231 | -2.24 | 0.67 |
Small inducible cytokine subfamily A (Cys-Cys), member 25 | SCYA25 | NM_005624 | -3.76 | 0.72 |
Monoglyceride lipase | MGLL | NM_007283 | -4.66 | 0.43 |
Interferon (alpha, beta and omega) receptor 1 | IFNAR1 | NM_000629 | -2.39 | 0.81 |
Insulin-like growth factor binding protein 6 | IGFBP6 | NM_002178 | -3.53 | 0.62 |
Metabolic enzyme | ||||
Serine protease inhibitor, Kunitz type, 2 | SPINT2 | NM_021102 | -5.44 | 0.46 |
Protein phosphatase 2, regulatory subunit B (B56), alpha isoform | PPP2R5A | NM_006243 | -7.12 | 0.37 |
Protein tyrosine phosphatase, non-receptor type 2 | PTPN2 | NM_002828 | -19.73 | 0.23 |
Deoxyribonuclease I-like 3 | DNASE1L3 | NM_004944 | -8.23 | 0.29 |
Cathepsin L | CTSL | NM_001912 | -4.39 | 0.37 |
Cell death regulator | ||||
Caspase 3, apoptosis-related cysteine protease | CASP3 | NM_004346 | -14.57 | 0.29 |
Programmed cell death 10 | PDCD10 | NM_007217 | -7.19 | 0.36 |
DNA damage response | ||||
Ataxia telangiectasia and Rad3 related | ATR | NM_001184 | -4.78 | 0.48 |
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kD) | XRCC5 | NM_021141 | -2.59 | 0.73 |
Mouse double min 2 | MDM2 | NM_002392 | -6.37 | 0.51 |
Growth/differentiation factor | ||||
Bone morphogenetic protein 5 | BMP5 | NM_021073 | -2.78 | 0.53 |
Keratin 4 | KRT4 | NM_002272 | -3.12 | 0.62 |
Keratin 13 | KRT13 | NM_002274 | -4.24 | 0.48 |
Connective tissue growth factor | CTGF | NM_001901 | -5.51 | 0.42 |
Others | ||||
Heat shock 70kDa protein 4 | HSPA4 | AB023420 | -3.19 | 0.56 |
Retinoid X receptor, α | RXRA | NM_002957 | -2.89 | 0.77 |
Ubiquitin-activating enzyme E1-like | UBE1L | NM_003335 | -2.95 | 0.53 |
Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | SLC25A5 | NM_001152 | -6.18 | 0.46 |
- Citation: Lee CF, Ling ZQ, Zhao T, Fang SH, Chang WC, Lee SC, Lee KR. Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. World J Gastroenterol 2009; 15(3): 356-365
- URL: https://www.wjgnet.com/1007-9327/full/v15/i3/356.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.356